The correlation of PROX1 overexpression with poorer prognosis in cases of gastric cancer is also reported in the study conducted by Ueta et al. Patients with high PROX1 expression had significantly lower 5-year OS and a lower recurrence-free survival rate compared to their low-PROX1-expressing counterparts. This evidence concerns the gene PROX1 and gastric cancer.